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A molecular understanding of the biological pheno-
mena orchestrated by lysine N3-methylation is
impeded by the challenge of producing site-specifi-
cally and quantitatively methylated histones. Here,
we report a general method that combines genetic
code expansion and chemoselective reactions, for
the quantitative, site-specific installation of dimethyl-
lysine in recombinant histones. We demonstrate the
utility of our method by preparing H3K9me2 and
show that this modified histone is specifically recog-
nized by heterochromatin protein 1 beta. Extensions
of the strategy reported here will allow a range of
chemoselective reactions (which have been used
for residue-selective, but not site-selective protein
modification) to be leveraged for site-specific protein
modification.
INTRODUCTION
The N3-modification status of specific lysine residues on histone
proteins in chromatin regulates genomic imprinting, X chromo-
some inactivation, transcriptional regulation, heterochromatin
formation, and DNA repair and may define epigenetic status
(Ko¨hler and Villar, 2008; Martin and Zhang, 2005; Spivakov and
Fisher, 2007). Lysine residues in histones are subject to revers-
ible acetylation, ubiquitination, and mono-, di-, and trimethyla-
tion. The methylation status of lysine residues is controlled by
methylases and demethylases and the state and site of methyl-
ation may dictate biological fate in ways that are beginning to be
deciphered (Strahl and Allis, 2000).
A molecular understanding of the biological changes that may
be orchestrated by lysine N3-methylation is impeded by the chal-
lenge of producing site-specifically and quantitatively methyl-
ated histones. Methyltransferases have been used to methylate
histones, but it is challenging to control the site, or extent or
degree of methylation using these enzymes in vitro (Martino
et al., 2009). Furthermore, this approach requires the availability
of specific methyltransferase enzymes, many of which have not
yet been identified. Native chemical ligation has been used to
construct histones with modified N-terminal tails (Shogren-
Knaak et al., 2003, 2006), and the role of H2B ubiquitination in
the histone core has recently been investigated via an extension
of this approach using multiple ligations (McGinty et al., 2008,
2009). Thioether analogs of methylated lysines (Guo et al.,1072 Chemistry & Biology 17, 1072–1076, October 29, 2010 ª2010 E2008; Simon et al., 2007), in which the gmethylene unit of lysine
is replaced by a sulfur atom, can be installed in a protein. But,
while these analogs are simple to install they are 0.3 A˚ longer
than the native amino acid, decrease the pKa of the ammonium
proton by 1.1 unit, and have more degrees of freedom, which
may lead to altered specificity or affinity in binding interactions
(Gellman, 1991; Gloss and Kirsch, 1995). The differences
between the analogs and the natural modification make them
potentially problematic for discovering unknown properties of
the natural system or explaining known phenomena in molecular
detail.
We recently reported general methods that allow two impor-
tant histone modifications, N3-acetyl-L-lysine, and N3-methyl-L-
lysine, to be site-specifically incorporated in recombinant
proteins (Neumann et al., 2008; Nguyen et al., 2009). We evolved
an orthogonal pyrrolysyl-tRNA synthetase/tRNACUA pair to
incorporate N3-acetyl-L-lysine in response to the amber codon
(Neumann et al., 2008, 2009), while to install N3-methyl-L-lysine
we genetically directed the incorporation of N3-tert-butyloxycar-
bonyl-N3-methyl-L-lysine using an orthogonal pyrrolysyl-tRNA
synthetase/tRNACUA pair and subsequently removed the tert-
butyloxycarbonyl group under mild conditions to reveal
N3-methyl-L-lysine in the protein (Nguyen et al., 2009). We have
begun to use these methods to provide a molecular under-
standing of the roles of acetylation and monomethylation on
histone and nonhistone proteins in regulating cell and organism
function (Lammers et al., 2010; Neumann et al., 2009; Zhao et al.,
2010).
Unfortunately, simple extensions of the methods we previ-
ously reported do not allow the site-specific installation of
dimethyl-lysine in recombinant histones. The pyrrolysyl-tRNA
synthetase does not accept 3-N,N-dimethyl-L-lysine as a
substrate, and our efforts to evolve a pyrrolysyl-tRNA synthetase
for the direct genetic encoding of 3-N,N-dimethyl-L-lysine,
essentially as previously described for acetyl-lysine, did not yield
specific enzymes (data not shown). Moreover, we cannot extend
the method used for installing N3-methyl-L-lysine to installing
3-N,N-dimethyl-L-lysine because the required quaternary amine-
N3-tert-butyloxycarbonyl-N3-dimethyl-L-lysine is not stable.
It is well established that the amino groups of proteins can be
efficiently methylated by reductive alkylation (Means and
Feeney, 1968; Rayment, 1997), but it is challenging to site-
specifically alkylate one lysine in a histone protein that contains
numerous chemically identical lysine residues (for example,
histone H3 contains 13 lysines). We realized that, by using
a strategy involving a combination of genetic code expansion
and chemoselective chemistry, it might be possible to trace-
lessly differentiate one lysine in a protein from all the otherslsevier Ltd All rights reserved
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Figure 1. Strategy for Genetically Directing
the Site-Specific Incorporation of
Dimethyl-Lysine in Recombinant Histones
1 is N3-tert-butyloxycarbonyl-L-lysine, shown in
blue. Cbz-OSu is N-(benzyloxycarbonyl)succini-
mide which reacts with the N3-amine of lysine in
proteins to give N3-(benzyloxycarbonyl)-L-lysine.
TFA is trifluoroacetic acid, DIEA is N,N-diisopropy-
lethylamine, DMSO is dimethyl sulfoxide, HOSu is
N-(hydroxy)succinimide, DMAB is dimethylamine
borane, TFMSA is trifluoromethanesulfonic acid,
and DMS is dimethyl sulfide. The N-terminal amine
and its Cbz derivative are not shown for clarity.
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a chosen lysine residue.
RESULTS AND DISCUSSION
We reasoned that site-specific methylation of a lysine residue in
a protein might be achieved by (1) replacing the codon for the
lysine to be methylated with the amber codon, (2) genetically en-
coding a protected version of lysine in response to the amber
codon, (3) quantitatively protecting the remaining amino groups
in the protein under mild conditions, (4) specifically and quantita-
tively deprotecting the amino acid incorporated in response to
the amber codon, (5) specifically and quantitatively methylating
the amino group of the genetically encoded, deprotected amino
acid, and (6) effecting the removal of all the remaining protecting
groups under mild conditions (Figure 1).
To investigate the utility of this approach, we aimed to install
dimethyl-lysine at position 9 of histone H3, which is a physiolog-
ically important methylation site (Strahl and Allis, 2000; Fischle
et al., 2003; Kim et al., 2006). N3-tert-butyloxycarbonyl-L-lysine
(1) (see Figure S1 available online) is a good substrate for the
Methanosarcina barkeri pyrrolysyl-tRNA synthetase/tRNACUA
pair (MbPylRS/MbtRNACUA) and we have recently shown that 1
can be incorporated into recombinant histones in good yield
(Nguyen et al., 2009). Moreover we have specifically removed
the tert-butyloxycarbonyl group from N3-tert-butyloxycarbonyl-
N3-methyl-L-lysine in recombinant histones under mild con-
ditions (Nguyen et al., 2009). We prepared His6-H3K9-1
(N-terminally hexahistidine-tagged histone H3 containing 1 at
position 9), with a yield of 13mg per liter of culture, by expressing
his6-H3K9TAG in the presence of the MbPylRS/MbtRNACUA
pair. His6-H3K9-1 was purified by Ni-NTA chromatography andChemistry & Biology 17, 1072–1076, October 29, 2010 ªthe N-terminal His6 tag was removed by
TEV protease to reveal H3K9-1. ESI-MS
analysis of the purified H3K9-1 confirms
the incorporation of 1 into histone H3
(Figure 2A).
To protect the N-terminal amine and
12 epsilon amino groups of lysine residues
in H3K9-1, we treated the purified pro-
tein with N-(benzyloxycarbonyloxy)succi-
nimide (Cbz-OSu) in basic DMSO/6 M
Gdn-Cl (9:1) to obtain the globallyCbz-pro-
tected sample H3K9-1-(Cbz13). The Cbz
protection was complete after 1 hr atroom temperature, as demonstrated by ESI-MS of the Cbz-OSu-
treated sample (Figure 2B). We revealed the free amino group of
lysine 9 by treating H3K9-1-(Cbz13) with 9:6 trifluoroacetic acid
(TFA)/water at 4C. The ESI-MS spectrum of the TFA-treated
sample indicates that TFA treatment quantitatively removed the
Boc group from 1, while leaving the Cbz groups intact (Figure 2C).
Wemethylated the epsilon amino group of lysine 9 inH3K9-(Cbz13)
by reductive alkylation using formaldehyde and a dimethylamine
borane complex (Means and Feeney, 1968; Rayment, 1997). After
4hr,ESI-MSanalysisof thealkylatedsampledemonstrates that the
epsilon amino group of lysine 9 is quantitatively dimethylated to
yield H3K9me2-(Cbz13) (Figure 2D). To remove the Cbz groups,
we used a cocktail of trifluoromethanesulfonic acid (TFMSA)/tri-
fluoroacetic acid (TFA)/dimethylsulfide (DMS) (1:3:6) for 2 hr at
0C. Two milligrams of the deprotected protein (H3K9me2) was
recovered using the material from a 1 liter expression.
H3K9me2 prepared by our method was recognized by an anti-
body against H3K9me2 which does not recognize H3K9 and
H3K9me1 (Figure 3). Similarly H3K9me2 was not recognized
by an anti-H3K9me1 antibody. These experiments confirm the
presence of dimethyl-lysine at position 9 in H3. The ESI-MS
spectra of the deprotected protein revealed that greater than
90% of the sample was indeed H3K9me2 and top-down
MS/MS protein sequencing through the entire histone (Neumann
et al., 2009) confirmed that dimethyl-lysine was exclusively
incorporated at the genetically encoded site (Figures S2 and
S3). Traces of incompletely deprotected protein were subse-
quently removed by HPLC purification (Figure 2E).
To demonstrate the protein prepared using our approach is
functional in biochemical assays, we performed coimmunopre-
cipitations of heterochromatin protein 1 (HP1), a chromodo-
main-containing protein, which is known to specifically bind to2010 Elsevier Ltd All rights reserved 1073
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Figure 2. Synthesis and Characterization
of Histone H3K9me2
(A) ESI-MS analysis of the purified H3K9-1
produced by MbPylRS/tRNACUA pair revealed a
mass of 15,325.5 ± 1.0 Da (peak iA, expected
mass 15,325 Da). The disodium and phosphate
adducts, differing by 44 and 98 Da, respectively,
are also detected in the spectrum (peak iiA
and iiiA). These counter ions are often found asso-
ciated with positively charged proteins (Chowd-
hury et al., 1990). The peak of 15,269.5 Da (peak
ivA) may correspond to the loss of t-butyl from
the tert-butyloxycarbonyl group (56 Da) (Raju
et al., 2010).
(B) All the free amines in H3K9-1 are protected with
Cbz. ESI-MS analysis of H3bocK9(Cbz13) revealed
a mass of 17,068.0 ± 1.0 Da (peak iB, expected
mass 17,067 Da). Two peaks each differing by
134 Da are seen in the spectrum (peak iiB and
iiiB, and these may result from the reversible
protection of the imidazole functionality in histidine
residues) (Sieber and Riniker, 1987).The peak of
mass 16,968.5 Da (peak ivB) corresponds to loss
of Boc group (100 Da) during electrospray ioniza-
tion process (Raju et al., 2010).
(C) The Boc group of H3K9-1-(Cbz13) is quantita-
tively deprotected with 60% TFA. ESI-MS analysis
of TFA-treated H3K9-1-(Cbz13) revealed a mass of
16,965.0 ± 1.0 Da (peak iC, expected mass 16,967
Da). The minor peak of mass 17,100.0 Da (peak iiC)
corresponds to the overprotected polypeptide
H3K9(Cbz14). The peak of mass 16,875.0 Da
(peak iiiC) may correspond to loss of benzyl group
(90 Da) during electrospray ionization process.
(D) Quantitative dimethylation of histone H3 lysine
9 was performed by reductive alkylation of H3K9
(Cbz13) with formaldehyde and dimethylamine
borane complex. ESI-MS analysis of methylated
sample revealed a mass of 16,996.5 ± 1.0 Da
(peak iD, expected mass 16,995 Da) correspond-
ing to the addition of two methyl groups (+28 Da).
The minor peak of mass 17,131.0 Da (peak iiD)
corresponds to the overprotected polypeptide
H3K9me2(Cbz14).
(E) ESI-MS analysis of HPLC-purified H3K9me2
revealed a peak of 15,253.0 ± 1.0 Da (peak iE,
expected mass 15253 Da) (Figure S3).
See also Figures S1 and S2.
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Genetically Directing 3-N, N-Dimethyl-L-lysineshort peptides based on histone H3 tail containing mono-, di-, or
trimethylated K9 (Fischle et al., 2003; Kim et al., 2006).
HP1 immunoprecipitation of full-length H3, H3K9me1, and
H3K9me2, synthesized by our approach, allows us to demon-
strate that full-length H3K9me2, but not unmethylated H3, binds
specifically to HP1 (Figure 3B).
In conclusion, we have demonstrated a general method for
the site-specific installation of dimethyl-lysine in recombinant
histones. Extensions of the strategy reported here will allow
a range of chemoselective reactions (Hermanson, 1996) to be
leveraged for site-specific protein modification. Indeed, we
recently demonstrated that a similar approach can be used for
the first synthesis of atypical ubiquitin chains (Virdee et al.,1074 Chemistry & Biology 17, 1072–1076, October 29, 2010 ª2010 E2010). We are currently using this approach in combination
with methods for installing other modifications into histones to
understand how combinations of posttranslational modifications
program cellular outcomes and epigenetic inheritance.
SIGNIFICANCE
A molecular understanding of the biological phenomena
orchestrated by lysine N3-methylation is impeded by
the challenge of producing site-specifically and quantita-
tively methylated histones. Here, we demonstrate a general
method for the quantitative, site-specific installation of
dimethyl-lysine in recombinant histones. Extensions of thelsevier Ltd All rights reserved
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Figure 3. Characterization of H3K9me2 and
Its Binding to HP1
(A) H3 detection with an antibody to the C terminus
of H3, H3K9me1, and H3K9me2-specific anti-
bodies.
(B) Interaction between HP1b and methylated
H3K9. The immunoprecipitation of HP1b is
described in the Experimental Procedures. Anti C
terminus H3 was used to immunoprecipitate H3,
H3K9me1 or H3K9me2 in the presence of HP1b.
HP1b recognition was probed by immunoblotting
with an anti-HP1 antibody. i, 2% of total HP1b,
pd, ‘‘pull-down’’ assay.
See also Figure S2.
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Genetically Directing 3-N, N-Dimethyl-L-lysinestrategy reported here will allow a range of chemoselective
reactions (which have been used for residue selective, but
not site-selective protein modification) to be leveraged for
site-specific protein modification. We are currently using
our approach in combination with methods for installing
other modifications into histones to understand how combi-
nations of posttranslational modifications program cellular
outcomes and epigenetic inheritance.
EXPERIMENTAL PROCEDURES
Information on protein expression and purification, mass spectrometric anal-
ysis of recombinant histones, and immunoprecipitation of HP1b can be found
in the Supplemental Experimental Procedures.
Global Protection of Histone H3K9-1
Lyophilized histone H3K9-1 (12 mg, 810 nmol) was dissolved in 120 ml 6 M
Gdn-Cl and diluted with DMSO to 1.25 ml. DIEA (37 ml, 210 mmol) and Cbz-
Osu (53 mg, 21 mmol) were then added to a vigorously stirred solution. The
solution was further stirred for 1 hr at room temperature. The protected poly-
peptide was then precipitated with cold 1:1 MeOH/acetone (10 ml). The
precipitate was collected by centrifugation, washed with cold 1:1 MeOH/
acetone, and air-dried.
Deprotection of Boc Protecting Group
The globally protected protein, obtained from 12mg of H3K9-1, was dissolved
in cold 9:6 TFA/H2O and incubated at 4
C for 1 hr to deprotect the genetically
encoded Boc group. The protein was precipitated and washed with ice-cold
ether. The aqueous and ether layers were removed, and the precipitate was
allowed to air-dry.
Dimethylation of Histone H3K9-(Cbz)13
The protein was dissolved in 2 ml of 6 M Gdn-Cl, 100 mM phosphate buffer
(pH 7.5) by sonication. Dimethylation of histone H3K9-(Cbz)13 was carried
out using JBS methylation kit (Jena Bioscience). After 4 hr of reaction, the
protein was precipitated with cold 1:1 MeOH/acetone (10 ml). The precipitate
was collected by centrifugation, washedwith cold 1:1MeOH/acetone, and air-
dried. The protein was then dissolved in an ice-cold cocktail (2 ml) of 7:11:2
DMS/TFA/TfOH and further stirred for 2 hr on ice to deprotect Cbz groups.
The protein was precipitated with cold ether supplemented with 1% pyridine.
The precipitate was collected by centrifugation and washed twice with cold
ether. The dried precipitate was dissolved in unfolding buffer (8 M urea,
100 mM Na2HPO4 [pH 7.4], 500 mM NaCl). The protein was dialyzed in the
same buffer overnight at room temperature and subsequently extensively
dialyzed into 1 mM DTT to obtain histone H3K9me2. The overall yield of
recovered H3K9me2 was approximately 2mg (17%). The protein was further
purified by RP-HPLC using a gradient of 5%–75% Buffer B over 30 min at
a flow rate of 5 ml/min. Buffer A = 0.1%TFA in H2O, Buffer B = 10% Buffer A
in acetonitrile.Chemistry & Biology 17, 1072–1SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at doi:10.1016/
j.chembiol.2010.07.013.
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